Picture1.jpg
Imago BioSciences to Host Virtual Investor Event
December 01, 2021 08:00 ET | Imago Biosciences, Inc.
SOUTH SAN FRANCISCO, Calif., Dec. 01, 2021 (GLOBE NEWSWIRE) -- ​Imago BioSciences, Inc. (“Imago” or the “Company”) (Nasdaq: IMGO), a clinical stage biopharmaceutical company discovering new...
Picture1.jpg
Imago BioSciences to Present at Stifel 2021 Virtual Healthcare Conference
November 11, 2021 16:05 ET | Imago Biosciences, Inc.
SOUTH SAN FRANCISCO, Calif., Nov. 11, 2021 (GLOBE NEWSWIRE) -- Imago BioSciences, Inc. (“Imago”) (Nasdaq: IMGO), a clinical stage biopharmaceutical company discovering new medicines for the...
Picture1.jpg
Imago BioSciences Reports Third Quarter 2021 Financial Results and Provides Recent Business Updates
November 10, 2021 16:05 ET | Imago Biosciences, Inc.
SOUTH SAN FRANCISCO, Calif., Nov. 10, 2021 (GLOBE NEWSWIRE) -- Imago BioSciences, Inc. (“Imago”) (Nasdaq: IMGO), a clinical-stage biopharmaceutical company discovering new medicines for the...
July 30, 2021 - ROSEN LOGO.jpg
LGVN SHAREHOLDER ALERT: ROSEN, TOP RANKED NATIONAL INVESTOR ATTORNEYS, Encourages Longeveron Inc. Investors to Secure Counsel Before Important November 12 Deadline in Securities Class Action – LGVN
November 01, 2021 19:45 ET | The Rosen Law Firm PA
NEW YORK, Nov. 01, 2021 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Longeveron Inc. (NASDAQ: LGVN): (1) pursuant and/or...
22157.jpg
United States Biobanks Markets Analysis & Forecasts, 2016-2020 & 2021-2026
September 24, 2021 06:58 ET | Research and Markets
Dublin, Sept. 24, 2021 (GLOBE NEWSWIRE) -- The "United States Biobanks Market, By Type (Population Based Biobanks v/s Disease Oriented Biobanks), By Ownership, By Product, By Specimen Type, By...
22157.jpg
Global $15.52 Bn Cell Isolation (Human Cells and Animal Cells) Markets, Competition Forecast & Opportunities, 2026
June 18, 2021 06:13 ET | Research and Markets
Dublin, June 18, 2021 (GLOBE NEWSWIRE) -- The "Global Cell Isolation Market By Product (Consumables and Instruments), By Cell Type (Human Cells and Animal Cells), By Source, By Technique, By...
ExCellThera_RGB.png
Excellthera and Ossium Health Announce a Collaboration to Advance Their Technologies and Platforms to Improve Human Health
April 21, 2021 08:02 ET | ExCellThera
MONTREAL, April 21, 2021 (GLOBE NEWSWIRE) -- ExCellThera Inc., a clinical-stage cell and molecular medicine company delivering molecules and bioengineering solutions to expand stem and immune cells...
22157.jpg
Global Cell Isolation/Cell Separation Market (2020 to 2025) - Growing Focus on Personalized Medicine Presents Opportunities
December 22, 2020 06:13 ET | Research and Markets
Dublin, Dec. 22, 2020 (GLOBE NEWSWIRE) -- The "Cell Isolation/Cell Separation Market by Product (Reagents, Beads, Centrifuge), Cell Type (Human, Animal), Cell Source (Bone Marrow, Adipose),...
fior-markets-logo.jpg
Global Autologous Cell Therapy Market Is Expected to Reach USD 42.68 Billion by 2027 : Fior Markets
September 09, 2020 16:00 ET | Fior Markets
Newark, NJ, Sept. 09, 2020 (GLOBE NEWSWIRE) -- As per the report published by Fior Markets, the global autologous cell therapy market is expected to grow from USD 9.29 billion in 2019 and to reach...
ARUP Laboratories' Ronald Weiss Wins Prestigious Governor's Medals for Science and Technology
March 17, 2015 14:22 ET | ARUP Laboratories
SALT LAKE CITY, March 17, 2015 (GLOBE NEWSWIRE) -- Eight Utah individuals, including ARUP Laboratories Ronald Weiss, MD, were awarded the annual Governor's Medals for Science and Technology -- Utah's...